JPMorgan Chase & Co. filings document a bank holding company with worldwide financial services operations and multiple classes of exchange-listed securities. Periodic reports describe investment banking, consumer and small-business financial services, commercial banking, transaction processing and asset management, along with capital, assets and stockholders’ equity disclosures.
The company’s 8-K filings record material events and identify registered securities including JPM common stock, depositary shares representing fractional interests in non-cumulative preferred stock, and guarantees of notes and exchange-traded notes issued by JPMorgan Chase Financial Company LLC. Proxy materials cover board matters, executive compensation, equity awards, shareholder voting items and other governance disclosures.
JPMorgan Chase & Co. Chief Operating Officer Jennifer Piepszak reported a sale of JPMorgan common stock. On January 16, 2026, she sold 8,571 shares of common stock at a price of $312.7859 per share.
After this transaction, Piepszak beneficially owns 71,027 shares of JPMorgan common stock in direct ownership form. The filing covers only non-derivative common stock, with no derivative security transactions reported in this instance.
JPMorgan Chase & Co. insider transaction: Douglas B. Petno, Co-CEO of the Corporate & Investment Bank, reported selling 3,487 shares of JPMorgan Chase & Co. common stock on January 16, 2026. The shares were sold at a price of $312.7983 per share.
After this sale, he directly beneficially owned 369,126 shares of JPMorgan Chase & Co. common stock. In addition, 70,457 shares of common stock were reported as indirectly beneficially owned through family trusts.
JPMorgan Chase & Co. insider filing: CEO of Consumer & Community Banking Marianne Lake reported an indirect sale of 3,908 shares of JPMorgan common stock on January 16, 2026, coded as an open market sale. The shares were sold at a price of $312.7823 per share through grantor retained annuity trusts (GRATs).
Following this transaction, 121,035 shares of JPMorgan common stock are reported as indirectly held by GRATs associated with her. The filing also reports 79,035 shares held directly and 53,424 shares held indirectly through a family trust.
JPMorgan Chase & Co. General Counsel Stacey Friedman reported an indirect sale of JPM common stock on 01/16/2026. A grantor retained annuity trust associated with her disposed of 3,404 shares at a price of $312.7961 per share. Following this transaction, the trust held 65,353 JPM shares indirectly for her benefit. Separately, she reported 50,136 JPM shares held directly and 13,604 JPM shares held indirectly through a trust. This filing reflects changes in her reported beneficial ownership rather than any change to JPMorgan Chase & Co.’s operations or financial results.
JPMorgan Chase & Co. (JPM) executive Mary E. Erdoes, CEO of Asset & Wealth Management, reported an open-market sale of company stock. On 01/16/2026, she sold 5,732 shares of common stock at a price of $312.7841 per share, coded as an "S" transaction, which indicates a sale.
After this transaction, Erdoes beneficially owned 619,136 shares of JPMorgan Chase & Co. common stock in direct form. The filing covers only this non-derivative stock sale and shows no derivative security transactions.
JPMorgan Chase & Co. Chief Information Officer Lori A. Beer reported selling 2,047 shares of JPMorgan Chase common stock on January 16, 2026. The shares were sold at a price of $312.7968 per share.
After this transaction, Beer beneficially owns 62,499 shares of JPMorgan Chase common stock in direct ownership form, according to the filing.
JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum reported selling 2,893 shares of JPMorgan common stock on January 16, 2026. The shares were sold at a price of $312.7859 per share. After this transaction, Barnum directly beneficially owned 26,696 shares of JPMorgan common stock.
JPMorgan Chase & Co. Chief Risk Officer Ashley Bacon reported selling 7,364 shares of JPMorgan common stock on January 16, 2026 at a price of $312.791 per share. Following this transaction, Bacon directly beneficially owns 237,157 shares of JPMorgan common stock.
JPMorgan Chase & Co. common stock is proposed to be sold under a Rule 144 notice. The person for whose account the securities are to be sold listed 3,404 shares of common stock, with an aggregate market value of $1,064,758.00, to be sold through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026. The class is identified as common stock with $1 par value, and the filing notes that 2,696,272,576 shares of this class were outstanding.
The 3,404 shares were acquired on 03/25/2022 from the issuer as a result of awards granted by the issuer and are described as equity compensation. The form includes the standard representation that the person signing does not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.
A shareholder has filed a notice of proposed sale of 2,893 shares of common stock, to be sold on the NYSE through J.P. Morgan Securities LLC. Based on the information provided, the shares have an aggregate market value of 904,889.57 at the time of the notice, compared with 2,696,272,576 shares outstanding for the issuer. The securities were acquired on 01/13/2026 as a result of equity compensation awards granted by the issuer, meaning they were received as part of a compensation program rather than purchased for cash.